AINewsnow

BigHat Biosciences Closes $75M Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design

Insider Brief PRESS RELEASE — BigHat Biosciences, a clinical-stage, AI-driven protein therapeutics platform company, has announced the completion of a $75 million Series C financing, bringing its total funding raised to date to $223 million. The round was co-led by DFJ Growth Premji Invest with par…

Read the full story at AI Insider ↗

Timeline · 1 report

  1. 2026-09-25 16:04 · AI Insider
    BigHat Biosciences Closes $75M Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design

More stories

  1. Gemini 3.8 text-to-speech says hello — Google Gemini Blog
  2. Introducing Gemini 3.8 Live with Live Avatar — Google Gemini Blog
  3. OpenAI ‘agent’ hacked an Australian health service website — Financial Times AI
  4. Sam Altman’s remarks at the United Nations Security Council — OpenAI News
  5. Introducing Ray-Ban Meta Audio and More AI Glasses Styles — Meta Newsroom
  6. GPT-6 Sol surpasses Claude Opus 5 on Agents’ Last Exam at 60% lower cost — r/singularity
  7. A federal appeals court upholds DOD's Anthropic blacklisting, finding Claude's integration with DOD systems is "a statutorily covered national-security risk" (Ashley Capoot/CNBC) — Techmeme
  8. Google Is Sending an A.I. Data Center to Outer Space — New York Times Technology

Get the daily brief of stories like this at 6:30 every morning →